期刊文献+

三种血液净化方式对维持性血液透析患者白介素-18表达水平的影响

下载PDF
导出
摘要 目的观察低通量血液透析(LFHD)、高通量血液透析(HFHD)和血液透析滤过(HDF)对维持性血液透析(MHD)患者白介素-18(IL-18)表达水平的影响。方法 A组(LFHD)B组(HFHD)C组(HDF)各20例次,分别于血液净化前后检测血浆IL-18水平及外周血单个核细胞(PBMC)IL-18mRNA表达量。结果 3组血液净化前后血浆IL-18水平及PBMC IL-18mRNA表达量比较,A组B组较治疗前增加,差异有统计学意义(P<0.05),C组较治疗前差异无统计学意义(P>0.05),3组间比较,A组>B组>C组(P<0.05)。结论 HDF和HFHD对改善MHD患者微炎症状态优于常规血液透析,HDF更优于HFHD。
作者 赵天然 李卿
出处 《河北医药》 CAS 2013年第7期998-999,共2页 Hebei Medical Journal
基金 河北省科学技术研究与发展支撑计划项目(编号:06276161)
  • 相关文献

参考文献6

二级参考文献23

  • 1[1]Patrick L, Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature. Altern Med Rev, 2001, 6(3): 248
  • 2[2]Panichi V, Migliori M, De Pietro S, et al. The link of biocompatibility to cytokine production. Kidney Int, 2000, 58 Suppl 76S96
  • 3[3]Panichi V, Migliori M, De Pietro S, et al. C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif, 2000, 18(3): 183
  • 4[4]Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int, 2001, 59(2): 407
  • 5[5]Kaysen GA.The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol, 2001, 12(7): 1549
  • 6[6]Lonnemann G.Chronic inflammation in hemodialysis:the role of contaminated dialysate. Blood Purif, 2000, 18(3): 214
  • 7[7]Schindler R,Boenisch O,Fischer C, et al. Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol, 2000, 53(6): 452
  • 8[8]Shimoike T, Inoguchi T, Umeda F, et al. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy. Metabolism, 2000, 49(8): 1030
  • 9[9]Liu Nai Feng,SUN Zi Lin,LIU Bi Cheng. Clearance of increased serum advanced glycosylation end products in patients with end stage renal disease by hemodialysis. Acta Pharmacol Sin, 2000, 21(3): 276
  • 10[10]Schwenger V, Zeier M, Henle T, et al. Advanced glycation endproducts (AGEs) as uremic toxins. Nephron, 2001, 45(3): 172

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部